Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atosiban Versus Placebo in the Treatment of Late Threatened Preterm Birth

NCT05693688 is registered in ClinicalTrials.gov with Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) as lead sponsor.

NCT NCT05693688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05693688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atosiban Versus Placebo in the Treatment of Late Threatened Preterm Birth
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase
Phase 4
Overall status
Completed
Start date
December 1, 2017
Completion date
February 29, 2024
Enrollment
760 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

preterm birth